Purchase Order HHSF223201510728P
Award Date
9/3/15
Potential Completion Date
9/30/15
Potential Value
$135K
Federal Agency
Food and Drug Administration
Awardee
Axion Biosystems, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30309, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID HHSF223201510126A, was made by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The $219,708.00 firm-fixed-price purchase order is for the acquisition of a high-throughput microelectrode assay system, plus 4 years of preventive maintenance services. The award does not have a set-aside designation. Axion Biosystems is a provider of live cell...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer of specialized laboratory equipment. The $218,346.00 contract is for the Maestro Multiwell System and related service agreement. Axion Biosystems provides the FDA with its proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and consumables to support the agency's biomedical research and drug...
This is a $140,204.00 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services' Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the delivery of a Micro-Electrode Assay System, a specialized laboratory instrument used in biomedical research initiatives across agencies like the National Institutes of Health (NIH), EPA, and VA. As a small business set-aside, this award...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Axion Biosystems, Inc., a foreign-owned for-profit manufacturer based in Atlanta, Georgia. The contract is for the purchase of a multielectrode array system, with a ceiling value of $258,195.00 and a completion date of February 21, 2026. Axion Biosystems is a manufacturer of advanced live cell analysis technologies and laboratory equipment, including their Maestro...
This is a $23,690.00 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of advanced laboratory equipment based in Atlanta, Georgia. The contract is for the procurement of laboratory supplies and consumables to support the FDA's Center for Drug Evaluation and Research (CDER). This award is a small business set-aside and is not associated with a larger contract vehicle. Axion Biosystems has a history...
This federal contract award is for the procurement of microelectrode array (MEA) lab equipment, including the Maestro multi-well MEA system, from Axion Biosystems, Inc. The $163,750.00 firm fixed-price purchase order was issued by the Department of Health and Human Services' Food and Drug Administration. The contract has a completion date of December 1, 2022 and includes two 1-year post-warranty maintenance option periods. Axion Biosystems is a life science company that develops technologies for...
This is a $5,480 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Axion Biosystems, Inc., a foreign-owned manufacturer based in Atlanta, Georgia. The contract is for the delivery of well plates and microelectrodes, which are specialized laboratory equipment used for real-time monitoring of neural and cardiac cellular activities. The contract was set aside for small businesses. Axion Biosystems has a strong track record of providing advanced live cell...
This federal contract award, valued at $149,845.00, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS). The contract was awarded to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized live cell analysis technologies, primarily its Maestro multi-electrode array (MEA) systems and related instrumentation and consumables. The contract does not have a set-aside designation. Axion Biosystems...
The Department of Health and Human Services Food and Drug Administration awarded a $317,900 firm fixed price purchase order to Axion Biosystems, Inc. for the delivery of one Axion Biosystem Maestro Multi-Well Microelectrode Array system. The system will meet the technical requirements outlined in the FDA's February 2023 special notice, including integrated signal amplification, digitization and stimulation hardware, environmental controls, automated plate docking, stimulus design capabilities,...
This is a $130,289 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services, to Axion Biosystems, Inc., a foreign-owned, for-profit manufacturer of specialized laboratory equipment and instruments. The contract is for the delivery of Axion's proprietary Maestro multi-electrode array (MEA) systems, Maestro Apex automated incubators, and related accessories like optical stimulation modules...